FFR的重要实验-+PCR最新进展含FAME+II+5年结果.pptxVIP

PCR statement on PCI treatment for chronic Coronary Syndrome(CCS) Until today, role of PCI with DES implantation versus medical therapy in PTS with CCS showed: No or only a modest benefit in terms of survival or MI 生存率或者心梗无改善或改善不明显 improvement of symptoms and QoL 症状缓解或者生活质量改进 Mostly, trials did not use latest DES technologies;( thin struts, limus derivatives for restenosis prevention) 但这些研究都没有采用最新一代的支架技术 Recent trials re-assessed the role of PCI in CCS( lesions in stable CAD, or non-culprit lesions in stabilized ACS) 最近的研究重新评估了PCI在慢性冠脉综合征中的作用（稳定型冠心病的病变或稳定的急性冠脉综合征的非犯罪病变） 2018 年慢性冠脉综合征（CCS）最佳